CLINICAL_TRIALS
trial_result
· 2022-09-21
Clinical Trial Update: Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass [Phase 1, Phase 2]
Summary
Follow-up study 5-6 years after ILIT with Birch and Grass allergens for allergic rhinitis; completed Phase 1/2 trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lars Olaf Cardell | Conditions: Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED